Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2006 > Volume 15 Number 3 May 2006 > THROMBOSIS, EMBOLISM AND BLEEDING > Surgical Treatment of Prosthetic Valve Thrombosis: Ten Years’ Experience

Surgical Treatment of Prosthetic Valve Thrombosis: Ten Years’ Experience

Banu Lafci, Ibrahim Özsöyler, Mert Kestell?, Levent Yilik, Tayfun Göktogan, Nagihan Karahan, Cengiz Özbek, Ali Gürbüz

AtatŸrk Education and Research Hospital, Department of Cardiovascular Surgery

Background and aim of the study: Prosthetic valve thrombosis (PVT) is a rare, but serious, complication of heart valve replacement with a mechanical substitute. Herein is presented the authors’ surgical experience of 18 patients with PVT.
Methods: A total of 1,584 heart valve operations was performed in 1,365 patients at the authors’ institution between June 1995 and September 2005. Surgical reports of prosthetic valve reoperations over the same period were screened. Preoperative, operative and postoperative data were collected from the patient cohorts.
Results: Since July 1997, 18 patients (12 females, six males; mean age 35.9 ± 11.3 years; range: 22-60 years) presented with PVT. The subtherapeutic anticoagulation level was the major etiologic factor involved in the pathogenesis of PVT. Thrombosis occurred in the mitral position in 14 patients (78%), and in the aortic position in four (22%).


All mechanical valves implanted were bileaflet (1,097 St. Jude Medical, 324 CarboMedics, and 163 Sorin). The mean duration from valve replacement to PVT was 48.3 ± 15.4 months. The majority of patients presented with poor functional status (56% in NYHA class IV) and poor anticoagulation (INR £2 in 72% of cases). Valve re-replacement was performed for all patients. The 30-day mortality was 16.7%.
Conclusion: PVT is a potentially fatal complication of heart valve replacement. These acceptable results suggest that early surgical intervention might be a safe and effective treatment of choice in patients with PVT. Patients with mechanical valve prostheses should be informed adequately about the need for, and the importance of, an effective anticoagulation regimen.


The Journal of Heart Valve Disease 2006;15:400-403

Surgical Treatment of Prosthetic Valve Thrombosis: Ten Years’ Experience

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.